Dechra Pharmaceuticals PLC | |
Stock Exchange | Other OTC |
EPS |
$0.31 |
Market Cap |
$3.58 B |
Shares Outstanding |
102.33 M |
Public Float |
- |
Dechra Pharmaceuticals PLC | |
Stock Exchange | Frankfurt Stock Exchange |
EPS |
- |
Market Cap |
- |
Shares Outstanding |
102.33 M |
Public Float |
- |
Dechra Pharmaceuticals PLC | |
Stock Exchange | London Stock Exchange |
EPS |
GBP0.23 |
Market Cap |
GBP2.86 B |
Shares Outstanding |
102.33 M |
Public Float |
96.84 M |
Address |
Cheshire Business Park Northwich Cheshire CW9 7UA United Kingdom |
Employees | - |
Website | http://dechra.com |
Updated | 07/08/2019 |
Dechra Pharmaceuticals PLC is a holding company, which engages in the veterinary pharmaceuticals and related products business. It operates through the following segments: European Pharmaceuticals; North American Pharmaceuticals; and Pharmaceuticals Research and Development. The European Pharmaceuticals segment markets and sells licensed pharmaceuticals and specialist pet foods to the veterinary profession in Europe. |